中國聖牧(01432.HK)與現代牧業(01117.HK)等合資建設飼料加工基地
中國聖牧(01432.HK)公佈,於上月30日,公司附屬公司內蒙古聖牧,與主要股東蒙牛(02319.HK)持股的中國現代牧業(01117.HK)旗下的現代牧業,以及獨立第三方牡丹江萬鼎乳業及牡丹江陸港就建議成立合資企業訂立出資合作協議書,以在中國牡丹江市經濟技術開發區保稅物流園區建設飼料加工基地。
合資企業的註冊資本將爲1億元人民幣。現代牧業、牡丹江萬鼎乳業、牡丹江陸港及內蒙古聖牧各自的出資額將分別爲5,100萬元人民幣、2,200萬元人民幣、2,000萬元人民幣及700萬元人民幣。因此,現代牧業、牡丹江萬鼎乳業、牡丹江陸港及內蒙古聖牧,各自將分別持有合資企業51%、22%、20%及7%的股權。所有出資均爲現金出資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.